Apedia

Antibody Cd52 Lymphocyte Depletion T Cell Bone Marrow Allografts

Alemtuzumab is an antibody to CD52 used for lymphocyte depletion, for example, T-cell depletion during bone marrow allografts in treating chronic myeloid leukemia.

Alemtuzumab is een antilichaam tegen CD52 dat wordt gebruikt voor lymfocytenuitputting, zoals voor T-celuitputting tijdens beenmergtransplantaties bij de behandeling van chronische myeloïde leukemie.

Front Antibody to CD52 used for lymphocyte depletion, such as for T-cell depletion during bone marrow allografts used in treating chronic myeloid leukemia
Back alemtuzumab

Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.

Next card: Receptor peptides amino acid substitutions made t-cell contact

Previous card: Recombinant cd58–igg1 fusion protein blocks cd2 binding cd58

Up to card list: Janeway's Immunobiology 9th Edition Concept Flash Card